CATALYST DOSSIER · UPDATED 2026-11-05
$TRAW
biotech · convergence -13 · conviction AVOID
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $TRAW?
Quantitative
Net Income (CY2026Q2) : $-3.1M (-233.8% YoY)
Catalysts
Multi-spoke convergence : 5 convergent signals fired: earnings, sec_fda, auto_macro_adp_payrolls, auto_macro_durable_goods, auto_macro_fx_rates
Risks
Position-sizing discipline : Conviction AVOID (-13 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Earnings binary : Print-day moves can swing ±15% — gap risk both directions
Sympathy basket (cerebro)
APP via tech r=+0.81 sympathetic (score 19)
STEM via tech r=+0.81 sympathetic (score 19)
LBTYA via comms r=+0.62 sympathetic (score 16)
CHTR via comms r=+0.62 sympathetic (score 7)
Signals Firing
earnings sec_fda auto_macro_adp_payrolls auto_macro_durable_goods auto_macro_fx_rates
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-23 sec_top_gappers +8.8% +0.0% ✓ hit 2026-10-23 sec_top_moat_emerging +8.8% +0.0% ✓ hit 2026-10-22 sec_top_gappers -5.4% -8.1% — 2026-10-22 sec_top_moat_emerging -5.4% -8.1% — 2026-10-21 sec_top_gappers +0.0% -2.6% — 2026-10-21 sec_top_moat_emerging +0.0% -2.6% — 2026-10-20 sec_top_gappers +2.6% +0.0% ✓ hit 2026-10-20 sec_top_moat_emerging +2.6% +0.0% ✓ hit 2026-10-13 sec_top_gappers +2.4% -2.4% ✓ hit 2026-10-13 sec_top_moat_emerging +2.4% -2.4% ✓ hit 2026-10-12 sec_top_gappers +2.4% -2.4% ✓ hit 2026-10-12 sec_top_moat_emerging +2.4% -2.4% ✓ hit
Lifetime: 8/16 wins · hit-rate 50.0% on +2% intraday
Sympathy Basket APP via tech · score 19 STEM via tech · score 19 LBTYA via comms · score 16 CHTR via comms · score 7
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.